Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 2, 1997

View Archived Issues

Spotlight on fibrinogen antagonists

Ranitidine shows no benefit in psoriasis

Anti-IgE antibody inhibits allergen-induced EAR

ET antagonists for asthma

Neuroprotection with new lipid peroxidation inhibitor from Lilly

Clinical results reported for Senetek's Kinetin

Orally active RARgamma-specific retinoid with selective skin effects

Development update on Oncolym

New therapeutic action of aspirin reported by British researchers

Milrinone analogues as novel inotropic agents

Final results of BENESTENT-II trial presented

Novel antimicrobial agents discovered by Ortho

New inhibitors of platelet aggregation from Taiwan

New MMP and TNF inhibitor from Kanebo

TNT nears clinical trials

WHO endorses HIV test

Quadrant licenses platelet technology to Pall

Zambon discovers potent and selective NEP inhibitors

U.S. clearance for Femara

Link between high blood pressure and cancer debated

Reteplase is superior to alteplase in pulmonary embolism

Gene therapy for cardiovascular diseases

HRT and cardiovascular disease in women

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026